Apellis Pharmaceuticals Inc (APLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | APLS | PTCT | APGE | ||
| Company | Apellis Pharmaceuticals Inc | Ptc Therapeutics | Apogee Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 40.95 | 65.84 | 84.36 | ||
| High | 40.97 | 66.09 | 85.06 | ||
| Low | 40.93 | 64.27 | 82.42 | ||
| Latest | 40.97 | 64.88 | 83.05 | ||
| Change | unch | -0.61 | -0.50 | ||
| % Change | -0.01% | -0.93% | -0.60% | ||
| Volume | 2,223,985 | 343,071 | 154,113 | ||
| 20-Day Average Volume | 3,834,378 | 1,130,431 | 611,391 | ||
| Previous Close | 40.97 | 65.49 | 83.55 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 40.89 | 69.35 | 86.68 | ||
| 20-Day Raw Stochastic | 90.28% | 14.23% | 17.30% | ||
| 20-Day Relative Strength | 82.66 | 41.78 | 51.42 | ||
| Weighted Alpha | +26.21 | +31.38 | +103.33 | ||
| Today's Opinion | 100% Buy | 40% Sell | 80% Buy | ||
| Previous Opinion | 100% Buy | 40% Sell | 80% Buy | ||
| Last Month's Opinion | 24% Buy | 24% Sell | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.06% since 04/28/26 | -7.93% since 04/28/26 | -2.68% since 04/28/26 | ||
| Low | 40.93 on 05/05/26 | 63.18 on 05/01/26 | 80.52 on 05/04/26 | ||
| High | 40.99 on 04/29/26 | 69.18 on 04/29/26 | 85.63 on 04/29/26 | ||
| 1-Month | |||||
| %Chg | +1.37% since 04/02/26 | -4.54% since 04/02/26 | -1.49% since 04/02/26 | ||
| Low | 40.41 on 04/06/26 | 63.18 on 05/01/26 | 80.52 on 05/04/26 | ||
| High | 41.00 on 04/28/26 | 73.79 on 04/14/26 | 95.32 on 04/17/26 | ||
| 3-Month | |||||
| %Chg | +81.58% since 02/05/26 | -10.60% since 02/05/26 | +33.72% since 02/05/26 | ||
| Low | 16.83 on 03/30/26 | 61.43 on 03/06/26 | 60.35 on 02/09/26 | ||
| High | 41.00 on 04/28/26 | 75.00 on 02/06/26 | 95.32 on 04/17/26 | ||
| 6-Month | |||||
| %Chg | +105.34% since 11/05/25 | -9.86% since 11/05/25 | +49.83% since 11/05/25 | ||
| Low | 16.83 on 03/30/26 | 61.43 on 03/06/26 | 52.34 on 11/07/25 | ||
| High | 41.00 on 04/28/26 | 87.50 on 11/26/25 | 95.32 on 04/17/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 5,245,021 | 5,429,907 | 5,167,819 | ||
| Shares Outstanding, K | 128,021 | 82,912 | 61,853 | ||
| Annual Sales | 1,003,780,000 | 1,730,660,000 | 0 | ||
| Annual Net Income | 22,390,000 | 682,640,000 | -255,840,000 | ||
| Last Quarter Sales | 199,910,000 | 164,680,000 | 0 | ||
| Last Quarter Net Income | -58,950,000 | -134,970,000 | -69,390,000 | ||
| 60-Month Beta | -0.24 | 0.53 | 0.69 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.47 on 02/24/26 | -1.67 on 02/19/26 | -1.03 on 03/02/26 | ||
| Earnings Date | 05/06/26 | 05/07/26 | 05/11/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 315.08 | 8.42 | 0.00 | ||